undefined undefined
NaN.000
NaN.00%
Jason McCarthy, an analyst from Maxim Group, maintained the Buy rating on Daré ...
今天 03:45
HC Wainwright & Co. analyst Douglas Tsao reiterates Dare Bioscience (NASDAQ:DARE) with a Buy and maintains $6 price target.
05-15 22:43
Dare Bioscience (NASDAQ:DARE) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.06) by 16.67 percent. This is a 22.22 percent increase over losses of $(0.09) per share from
05-14 20:27
Major earnings expected after the bell on Tuesday include: Oxford Lane Capital Corp. (OXLC) Capital Southwest Corporation (CSWC) Seadrill Limited (SDRL) Nu Holdings Ltd. (NU) Canoo (GOEV) Other earnin...
05-14 05:35
Daré Bioscience (NASDAQ:DARE) on Tuesday announced it has closed a royalty monetization transaction with XOMA (US). Daré received $22 million in gross proceeds at close. DARE +8.76% premarket to $0.30...
04-30 20:43
Brookline Capital:下调Dare Bioscience(DARE.US)评级,由买入调整至持有评级。
04-18 01:30
Brookline Capital analyst Kemp Dolliver downgrades Dare Bioscience (NASDAQ:DARE) from Buy to Hold.
04-18 01:28
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts jus...
04-01 18:20
来源:北青网 3月26日,达芙妮国际发布2023年年报。2023年,公司实现总收益2.63亿元,同比增长53%;实现经营盈利6,764万元,同比增长59%;实...
04-01 10:02
12月31日,Dare Bioscience, Inc.(DARE.US)公布财报,公告显示公司2023财年净利润为-30.16百万美元,同比增加2.55%;其...
03-29 23:15